Jane Street Group, LLC Oyster Point Pharma, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$7.95 - $11.68 $1.61 Million - $2.37 Million
202,609 Added 1073.88%
221,476 $2.47 Million
Q3 2022

Nov 14, 2022
BUY
$4.41 - $8.38 $83,203 - $158,105
18,867 New
18,867 $106,000
Q1 2022

May 17, 2022
SELL
$8.58 - $17.65 $153,676 - $316,129
-17,911 Closed
0 $0
Q4 2021

Feb 15, 2022
BUY
$10.17 - $18.96 $182,154 - $339,592
17,911 New
17,911 $327,000

Others Institutions Holding OYST

# of Institutions
4
Shares Held
19K
Call Options Held
0
Put Options Held
0
View Full List

About Oyster Point Pharma, Inc.

OYST Quotes by TradingView
  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email